Showing results (1071-1080 of 1,144) with videos related to

Sort By:
Pageof 115
Allergy|May 17, 2019
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthmaIoana Agache, Susanne Lau, Cezmi A Akdis, et al.
Clinical and Translational Allergy|February 11, 2016
Allergen immunotherapy for allergic asthma: protocol for a systematic reviewSangeeta Dhami, Ulugbek Nurmatov, Ioana Agache, et al.
Human Genetics|March 21, 2020
Delineation of phenotypes and genotypes related to cohesin structural protein RAD21Lianne C Krab, Iñigo Marcos-Alcalde, Melissa Assaf, et al.
Clinical and Translational Allergy|September 22, 2017
Erratum to: Allergen immunotherapy for allergic asthma: protocol for a systematic reviewSangeeta Dhami, Ulugbek Nurmatov, Ioana Agache, et al.
Allergy|December 2, 2023
Telemedicine with special focus on allergic diseases and asthma-Status 2022: An EAACI position paperSylwia Smolinska, Florin-Dan Popescu, Elena Izquierdo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2015
Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 TrialNandita Khera, Navneet S Majhail, Ruta Brazauskas, et al.
Bone Marrow Transplantation|April 28, 2015
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcomeS D Goyal, M-J Zhang, H-L Wang, et al.
Expert Review of Cardiovascular Therapy|October 9, 2018
Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolismTarek Nafee, C Michael Gibson, Megan K Yee, et al.
International Ophthalmology|July 13, 2022
Anti-vascular endothelial growth factor therapy in diabetic macular edema: real-life outcomes from a multicenter study in Turkey over 36 monthsAli Hakan Durukan, Nurten Unlu, Mehmet Onen, et al.
Medicina (Kaunas, Lithuania)|February 25, 2023
Real Life Multicenter Comparison of 24-Month Outcomes of Anti-VEGF Therapy in Diabetic Macular Edema in Turkey: Ranibizumab vs. Aflibercept vs. Ranibizumab-Aflibercept SwitchMurat Kucukevcilioglu, Yağmur Seda Yeşiltaş, Ali Hakan Durukan, et al.
Pageof 115